L
L. E. Arnold
Researcher at Ohio State University
Publications - 15
Citations - 5746
L. E. Arnold is an academic researcher from Ohio State University. The author has contributed to research in topics: Attention deficit hyperactivity disorder & Mental health. The author has an hindex of 14, co-authored 15 publications receiving 5548 citations. Previous affiliations of L. E. Arnold include University of California, San Francisco & University of California, Berkeley.
Papers
More filters
Journal ArticleDOI
A 14-Month Randomized Clinical Trial of Treatment Strategies for Attention-Deficit/Hyperactivity Disorder
P. S. Jensen,L. E. Arnold,Je Richters,Jb Severe,D Vereen,Benedetto Vitiello,E. Schiller,Stephen P. Hinshaw,Gr Elliott,C.K. Conners,Kc Wells,John S. March,James M. Swanson,Timothy Wigal,Dennis P. Cantwell,Hb Abikoff,J Hechtman,Ll Greeenhill,Jh Newcorn,We Pelham,B Hoza,Hk Kraemer +21 more
TL;DR: In this paper, a group of 579 children with ADHD Combined Type, aged 7 to 9.9 years, were assigned to 14 months of medication management (titration followed by monthly visits); intensive behavioral treatment (parent, school, and child components, with therapist involvement gradually reduced over time); the two combined; or standard community care (treatments by community providers).
Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder
P. S. Jensen,L. E. Arnold,Je Richters,Jb Severe,D Vereen,Benedetto Vitiello,E. Schiller,Stephen P. Hinshaw,Gr Elliott,C.K. Conners,Kc Wells,John S. March,James M. Swanson,Timothy Wigal,Dennis P. Cantwell,Hb Abikoff,J Hechtman,Ll Greeenhill,Jh Newcorn,We Pelham,B Hoza,Hk Kraemer +21 more
TL;DR: In children with ADHD plus anxiety, behavioral treatment surpassed community care and approached medication-based treatments regarding parent-reported ADHD symptoms, and results were upheld across most baseline variables and treatment acceptance/attendance.
Journal ArticleDOI
National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder
P. S. Jensen,L. E. Arnold,Jb Severe,Benedetto Vitiello,Kimberly Hoagwood,Stephen P. Hinshaw,Gr Elliott,C.K. Conners,Kc Wells,John S. March,James M. Swanson,Dennis P. Cantwell,Timothy Wigal,Hb Abikoff,J Hechtman,Ll Greeenhill,Jh Newcorn,We Pelham,B Hoza,Hk Kraemer,Rd Gibbons,E. Schiller +21 more
TL;DR: The MTA medication strategy showed persisting significant superiority over Beh and CC for ADHD and oppositional-defiant symptoms at 24 months, although not as great as at 14 months.
Journal Article
National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment
P. S. Jensen,L. E. Arnold,Jb Severe,Benedetto Vitiello,Kimberly Hoagwood,Stephen P. Hinshaw,Gr Elliott,C.K. Conners,Kc Wells,John S. March,James M. Swanson,Dennis P. Cantwell,Timothy Wigal,Hb Abikoff,J Hechtman,Ll Greeenhill,Jh Newcorn,We Pelham,B Hoza,Hk Kraemer,Rd Gibbons,E. Schiller +21 more
TL;DR: In the MTA follow-up, exploratory naturalistic analyses suggest that consistent use of stimulant medication was associated with maintenance of effectiveness but continued mild growth suppression.
Journal ArticleDOI
National Institute of Mental Health Collaborative Multimodal Treatment Study of Children With ADHD (the MTA): Design Challenges and Choices
L. E. Arnold,Hb Abikoff,Dennis P. Cantwell,C.K. Conners,Gr Elliott,L. Greenhill,Lily Hechtman,Stephen P. Hinshaw,B Hoza,P. S. Jensen,Helena C. Kraemer,John S. March,Jeffrey H. Newcorn,We Pelham,John E. Richters,E. Schiller,Joanne B. Severe,James M. Swanson,D Vereen,Karen C. Wells +19 more
TL;DR: The Collaborative Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder (ADHD), the MTA, is the first child multisite cooperative agreement treatment study of children conducted by the National Institute of Mental Health and compares state-of-the-art treatment with routine community care.